Funding, M&A, exec moves and hiring — every signal, the moment it breaks.See plans →
RevealDx received $3.4M investment from 4DMedical to expand access to RevealAI-Lung. This funding will enhance their AI software for lung nodule characterization.
PRIVATEAug 07, 2026•about 18 hours ago
Amount Raised
$3.4 Million
Round Type
Seed
Investors
4 D Medical
Description
RevealDx, a Seattle-based provider of medical imaging AI software, secured a $3.4M investment from 4DMedical. The funds will be used to expand access to their flagship product, RevealAI-Lung. The platform aids in characterizing incidental lung nodules and assists radiologists in cancer diagnosis. RevealDx holds various certifications and has a presence in clinical sites across Europe and the U.S.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Watching RevealDx? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan